{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:13:54Z","timestamp":1761164034109,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","techvir.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Techniques in Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1053\/j.tvir.2005.03.003","type":"journal-article","created":{"date-parts":[[2005,9,28]],"date-time":"2005-09-28T07:08:36Z","timestamp":1127891316000},"page":"81-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyperacute Therapy of Ischemic Stroke: Intravenous Thrombolysis"],"prefix":"10.1053","volume":"8","author":[{"given":"Reza","family":"Jahan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.tvir.2005.03.003_bib1","first-page":"1407","article-title":"WHO Task Force","volume":"20","year":"1989","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib2","series-title":"Stroke","first-page":"19","article-title":"Epidemiology of strokes in North America","author":"Wolf","year":"1986"},{"key":"10.1053\/j.tvir.2005.03.003_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.37.2.221","article-title":"Prognosis of acute stroke","volume":"37","author":"Chambers","year":"1987","journal-title":"Neurology"},{"key":"10.1053\/j.tvir.2005.03.003_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.STR.29.2.415","article-title":"The Greater Cincinnati\/Northern Kentucky Stroke Study","volume":"29","author":"Broderick","year":"1998","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-109-10-805","article-title":"When and how to study the carotids","volume":"109","author":"Feussner","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.tvir.2005.03.003_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.STR.28.3.500","article-title":"Stroke trends in the WHO MONICA project","volume":"28","author":"Thorvaldsen","year":"1997","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0733-8627(20)30280-7","article-title":"Stroke intervention","volume":"8","author":"Barnaby","year":"1990","journal-title":"Emerg Med Clin North Am"},{"issue":"suppl 1","key":"10.1053\/j.tvir.2005.03.003_bib8","first-page":"S10","article-title":"The economic impact of stroke","volume":"45","author":"Dobbin","year":"1995","journal-title":"Neurology"},{"key":"10.1053\/j.tvir.2005.03.003_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1052-5149(25)00095-4","article-title":"Intravascular thrombolysis in central nervous system cerebrovascular disease","volume":"2","author":"Zeumer","year":"1992","journal-title":"Neurol Clin North Am"},{"key":"10.1053\/j.tvir.2005.03.003_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ana.410320113","article-title":"Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke","volume":"32","author":"del Zoppo","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1053\/j.tvir.2005.03.003_bib11","first-page":"4","article-title":"PROACT","volume":"29","author":"del Zoppo","year":"1998","journal-title":"PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.tvir.2005.03.003_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000015955","article-title":"Mapping the ischaemic penumbra with PET","volume":"9","author":"Baron","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"10.1053\/j.tvir.2005.03.003_bib14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.STR.30.7.1486","article-title":"Which targets are relevant for therapy of acute ischemic stroke?","volume":"30","author":"Heiss","year":"1999","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib15","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/01.STR.29.9.1778","article-title":"Time course of ADC changes in ischemic stroke","volume":"29","author":"Nagesh","year":"1998","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1212\/WNL.50.3.599","article-title":"Factors determining the therapeutic window for stroke","volume":"50","author":"Zivin","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/j.tvir.2005.03.003_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/neu.1997.14.313","article-title":"Histopathologic clues to the pathways of neuronal death following ischemia","volume":"14","author":"Rosenblum","year":"1997","journal-title":"J Neurotrauma"},{"issue":"suppl","key":"10.1053\/j.tvir.2005.03.003_bib18","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1038\/399a007","article-title":"The changing landscape of ischemic brain injury mechanisms","volume":"399","author":"Lee","year":"1999","journal-title":"Nature"},{"key":"10.1053\/j.tvir.2005.03.003_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.STR.29.3.705","article-title":"Calcium in ischemic cell death","volume":"29","author":"Kristian","year":"1998","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/BF01700973","article-title":"Critical care of acute ischemic stroke","volume":"21","author":"Hacke","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.tvir.2005.03.003_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.STR.12.6.723","article-title":"Thresholds in cerebral ischemia\u2014the ischemic penumbra","volume":"12","author":"Astrup","year":"1981","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.tvir.2005.03.003_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199607183350301","article-title":"Thrombolytic therapy with streptokinase in acute ischemic stroke","volume":"335","year":"1996","journal-title":"N Eng J Med"},{"key":"10.1053\/j.tvir.2005.03.003_bib24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","article-title":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.tvir.2005.03.003_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1996.03540120039031","article-title":"Streptokinase for acute ischemic stroke with relationship to time of administration","volume":"276","author":"Donnan","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.tvir.2005.03.003_bib26","first-page":"1017","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke","volume":"274","author":"Hacke","year":"1995","journal-title":"The European Cooperative Acute Stroke Study (ECASS). JAMA"},{"key":"10.1053\/j.tvir.2005.03.003_bib27","first-page":"1245","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"352","author":"Hacke","year":"1998","journal-title":"Second European-Australasian Acute Stroke Study Investigators. Lancet"},{"key":"10.1053\/j.tvir.2005.03.003_bib28","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.tvir.2005.03.003_bib29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1084\/jem.58.4.485","article-title":"The fibrinolytic activity of hemolytic streptococci","volume":"58","author":"Tillet","year":"1933","journal-title":"J Exp Med"},{"key":"10.1053\/j.tvir.2005.03.003_bib30","first-page":"727","article-title":"A pilot study of streptokinase for acute cerebral infarction","volume":"88","author":"Morris","year":"1995","journal-title":"QJM"},{"key":"10.1053\/j.tvir.2005.03.003_bib31","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/01.STR.31.7.1555","article-title":"Streptokinase in acute ischemic stroke: an individual patient data metaanalysis: the Thrombolysis in Acute Stroke Pooling Project","volume":"31","author":"Cornu","year":"2000","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib32","first-page":"CD000213","article-title":"Thrombolysis for acute ischemic stroke (Cochrane Review)","volume":"2","author":"Wardlaw","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.tvir.2005.03.003_bib33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1212\/WNL.47.3.835","article-title":"Report of the Quality Standards Subcommittee of the American Academy of Neurology: Practice advisory: thrombolytic therapy for acute ischemic stroke-summary statement","volume":"47","year":"1996","journal-title":"Neurology"},{"key":"10.1053\/j.tvir.2005.03.003_bib34","first-page":"288","article-title":"The NINDS rt-PA Stroke Study","volume":"29","author":"Kwiatkowski","year":"1998","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib35","first-page":"1781","article-title":"Effects of tissue plasminogen activator for acute ischemic stroke at one year","volume":"340","author":"Kwiatkowski","year":"1999","journal-title":"National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Eng J Med"},{"key":"10.1053\/j.tvir.2005.03.003_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-2008-1040900","article-title":"Recanalization therapies for acute ischemic stroke","volume":"18","author":"Broderick","year":"1998","journal-title":"Semin Neurol"},{"key":"10.1053\/j.tvir.2005.03.003_bib37","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib38","first-page":"2119","article-title":"Generalized efficacy of t-PA for acute stroke","volume":"28","year":"1997","journal-title":"Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.STR.29.1.18","article-title":"Intravenous tissue plasminogen activator for acute ischemic stroke","volume":"29","author":"Chiu","year":"1998","journal-title":"Stroke"},{"key":"10.1053\/j.tvir.2005.03.003_bib40","first-page":"424","article-title":"Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke","volume":"53","author":"Tanne","year":"1999","journal-title":"The t-PA Stroke Survey Group. Neurology"},{"key":"10.1053\/j.tvir.2005.03.003_bib41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.1995.00540350113023","article-title":"Conditions that mimic stroke in the emergency department. Implications for acute stroke trials","volume":"52","author":"Libman","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1053\/j.tvir.2005.03.003_bib42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jama.283.9.1145","article-title":"Intravenous tissue-type plasminogen activator for treatment of acute stroke","volume":"283","author":"Albers","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.tvir.2005.03.003_bib43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.283.9.1151","article-title":"Use of tissue-type plasminogen activator for acute ischemic stroke","volume":"283","author":"Katzan","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.tvir.2005.03.003_bib44","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"CAST","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.tvir.2005.03.003_bib45","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The international Stroke trial (IST)","volume":"349","author":"Sandercock","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.tvir.2005.03.003_bib46","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/ajhp\/55.22.2363","article-title":"Glycoprotein IIb\/IIIa antagonists in the management of cardiovascular diseases","volume":"55","author":"Chong","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.tvir.2005.03.003_bib47","first-page":"956","article-title":"The EPIC Investigation","volume":"330","year":"1994","journal-title":"N Eng J Med"},{"key":"10.1053\/j.tvir.2005.03.003_bib48","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.tvir.2005.03.003_bib49","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.tvir.2005.03.003_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade. Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.tvir.2005.03.003_bib51","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.97.17.1680","article-title":"Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb\/IIIa receptor blockade","volume":"97","author":"Mascelli","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/j.tvir.2005.03.003_bib52","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.90.4.1757","article-title":"Pharmacodynamics of chimeric glycoprotein IIb\/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty","volume":"90","author":"Tcheng","year":"1994","journal-title":"Circulation"},{"key":"10.1053\/j.tvir.2005.03.003_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/01.STR.31.3.601","article-title":"Abciximab in acute ischemic stroke. a randomized, double-blind, placebo-controlled, dose-escalation study","volume":"31","year":"2000","journal-title":"Stroke"}],"container-title":["Techniques in Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251605000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251605000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:50:32Z","timestamp":1761069032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089251605000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1089251605000132"],"URL":"https:\/\/doi.org\/10.1053\/j.tvir.2005.03.003","relation":{},"ISSN":["1089-2516"],"issn-type":[{"type":"print","value":"1089-2516"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperacute Therapy of Ischemic Stroke: Intravenous Thrombolysis","name":"articletitle","label":"Article Title"},{"value":"Techniques in Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.tvir.2005.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}